Press release
Macular Edema and Macular Degeneration Market Poised for 7.1% Growth, Set to Hit $304.52 Billion by 2029
Macular Edema and Macular Degeneration Market
The growth of the macular edema and macular degeneration market is predicted to be driven by the escalating number of individuals suffering from diabetes. Diabetes is a long-term health condition that results in elevated levels of glucose in the bloodstream. The condition harms the eye's blood vessels, potentially leading to macular edema and macular degeneration. As an illustration, the National Health Service (NHS England), a publicly funded healthcare organization located in the UK, reported in June 2024 that the quantity of individuals predicted as pre-diabetic by the NHS in England had risen to 3,615,330 by 2023, showing an 18% escalation from 3,065,825 in the preceding year. Even more striking is the almost 25% rise in cases among those aged below 40, rising from 173,166 in 2022 to 216,440 in 2023. Hence, the burgeoning diabetes demographic is propelling the growth of these market sectors. Macular Edema and Macular Degeneration Market Driver: Growth in Macular Edema And Macular Degeneration Market Spurred by Rising Incidences of Eye Disorders
Get Your Macular Edema and Macular Degeneration Market Report Here:
https://www.thebusinessresearchcompany.com/report/macular-edema-and-macular-degeneration-global-market-report
What growth opportunities are expected to drive the macular edema and macular degeneration market's CAGR through 2034?
The market for macular edema and macular degeneration has seen robust growth in the past few years. The market value is predicted to rise from $9.65 billion in 2024 to $10.43 billion in 2025, with a compound annual growth rate (CAGR) of 8.1%. Factors contributing to the growth during the historical period include an aging population, high diabetes prevalence, awareness and early detection, global commitments towards eye health, advancements in pharmaceuticals, and support and advocacy for patients.
The market for macular edema and macular degeneration is predicted to record significant expansion in the coming years, estimated to reach $13.71 billion by 2029, with a compound annual growth rate (CAGR) of 7.1%. Factors contributing to this growth during the forecasted period include personalized medicine strategies, increased awareness in rising markets, emphasis on combined treatments, collaboration with teleophthalmology services, and the worldwide aging population. Key future trends will involve progress in sustained-release drug delivery, the incorporation of gene therapies, the emergence of innovative imaging technologies, personalized care plans centered on biomarkers, remote monitoring via teleophthalmology, and advancements in AI-based diagnostics.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13479&type=smp
What are the emerging trends shaping the future of the macular edema and macular degeneration market?
In order to maximize their profits in the macular edema and macular degeneration market, leading corporations are concentrating on the innovation and development of new products like Vabysmo (faricimab-svoa). This particular drug, used in the treatment of diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD), was approved by the Food and Drug Administration in January 2022. Genentech Inc., a renowned biotechnology company based in the United States, was responsible for this breakthrough. Vabysmo (faricimab-svoa) is a unique bispecific antibody that targets angiopoietin 2 (Ang-2) as well as vascular endothelial growth factor (VEGF), becoming the first of its kind for these conditions. The projected success of Faricimab in the treatment of nAMD and DME, symbolized by the approval from both FDA and EU, marks a substantial achievement for both Genentech and Roche.
Which growth-oriented segments of the macular edema and macular degeneration market are leading the industry's development?
The macular edema and macular degeneration market covered in this report is segmented -
1) By Treatment Type: Drug Therapy, Laser Treatment
2) By Application: Macular Edema, Diabetic Macular Edema (DME), Cystoid Macular Edema (CME), Macular Degeneration, Dry age-related macular degeneration, Wet age-related macular degeneration
3) By End User: Hospitals, Clinics, Other End Users
Subsegments:
1) By Drug Therapy: Anti-VEGF (Vascular Endothelial Growth Factor) Injections, Steroid Injections, Oral Medications, Combination Therapy (Anti-VEGF + Steroids)
2) By Laser Treatment: Focal Laser Photocoagulation, Panretinal Photocoagulation (PRP), Subthreshold Laser Therapy, MicroPulse Laser Therapy
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13479
What regions are leading the charge in the macular edema and macular degeneration market?
North America was the largest region in the macular edema and macular degeneration market in 2024. The regions covered in the macular edema and macular degeneration market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What companies are at the forefront of innovation in the macular edema and macular degeneration market?
Major companies operating in the macular edema and macular degeneration market report are F. Hoffmann La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, GlaxoSmithKline PLC, Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Bausch Health Companies Inc., Clover Therapeutics Inc., Santen Pharmaceutical Co. Ltd., Samsung Bioepis Inc., PanOptica Inc., Regen X Bio Inc., Aerie Pharmaceutical Inc., Apellis Pharmaceuticals Inc., Kubota Pharmaceutical Holdings Co. Ltd., Alimera Sciences Inc., Kodiak Sciences Inc., Acucela Inc., Editas Medicine Inc., IVERIC bio Inc., Lineage Cell Therapeutics Inc., Allegro Ophthalmic Ltd., Ampio Pharmaceuticals Inc., Neurotech Pharmaceuticals Inc., Graybug Vision Inc., Clearside Biomedical Inc., Ocugen Inc., Opthea Limited
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13479&type=smp
What Is Covered In The Macular Edema and Macular Degeneration Global Market Report?
•Market Size Forecast: Examine the macular edema and macular degeneration market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the macular edema and macular degeneration market for a structured understanding.
•Key Players Overview: Analyze major players in the macular edema and macular degeneration market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the macular edema and macular degeneration market.
•Segment Contributions: Evaluate how different segments drive overall growth in the macular edema and macular degeneration market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the macular edema and macular degeneration market.
•Industry Challenges: Identify potential risks and obstacles affecting the macular edema and macular degeneration market.
•Competitive Landscape: Review strategic developments in the macular edema and macular degeneration market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Macular Edema and Macular Degeneration Market Poised for 7.1% Growth, Set to Hit $304.52 Billion by 2029 here
News-ID: 3914103 • Views: …
More Releases from The Business Research Company
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the M …
The meal replacement market is gaining significant momentum as consumer preferences shift toward convenient and health-focused nutrition solutions. With rising awareness about preventive healthcare and personalized diets, this sector is set for considerable expansion. Let's explore how the market size is expected to evolve, who the key players are, emerging trends, and the main segments driving this growth.
Projected Growth Trajectory of the Meal Replacement Market Size
The meal replacement…
Leading Companies Reinforcing Their Presence in the Malted Barley Market
The malted barley industry is positioned for steady expansion as demand grows across various sectors. With increasing interest from craft brewers and functional food producers, this market is set to experience meaningful growth driven by innovation and sustainability efforts. Let's dive into the current market size, key players shaping the industry, trends influencing its trajectory, and detailed segment insights.
Projected Market Size and Growth Outlook of the Malted Barley Market …
Future Perspective: Key Trends Shaping the Low-calorie Food Market up to 2030
The low-calorie food market is poised for significant expansion as consumer preferences shift toward healthier eating habits and more personalized nutrition options. Advances in product innovation and supportive regulatory frameworks are expected to drive rapid growth over the coming years. Here's an overview of the market size, key players, emerging trends, and segmentation shaping this evolving industry.
Projected Expansion of the Low-calorie Food Market Size Through 2030
The low-calorie food…
Competitive Landscape: Leading Companies and New Entrants in the Liquid Nutritio …
The liquid nutritional supplement sector is on the rise, driven by evolving consumer preferences and innovations in health and wellness. With growing awareness about personalized nutrition and preventive healthcare, this market is set to witness substantial growth over the coming years. Let's explore the market's projected size, major players, emerging trends, and key segments shaping this dynamic industry.
Projected Market Value and Growth Trajectory of the Liquid Nutritional Supplement Market …
More Releases for Macular
Elevated Diabetes Prevalence Fuels Growth In The Macular Edema And Macular Degen …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Macular Edema and Macular Degeneration Market Size By 2025?
The market encompassing macular edema and macular degeneration has experienced substantial expansion recently, projected to increase from a value of $9.65 billion in 2024 to $10.33 billion in 2025, reflecting a compound annual growth rate (CAGR)…
2025-2034 Macular Edema and Macular Degeneration Market Roadmap: Insights for Co …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
How Large Will the Macular Edema and Macular Degeneration Market Size By 2025?
In the past few years, the market size for macular edema and macular degeneration has seen significant growth. It is projected to increase from $9.65 billion in 2024 to $10.43 billion in 2025, exhibiting a compound…
Macular Edema and Macular Degeneration Market Outlook 2025-2034: Key Trends, Gro …
"How Big Is the Macular Edema and Macular Degeneration Market Expected to Be, and What Will Its Growth Rate Be?
The macular edema and macular degeneration market has seen significant growth in recent years. It will expand from $9.65 billion in 2024 to $10.43 billion in 2025, with a CAGR of 8.1%. Factors contributing to this growth include the aging population, increasing diabetes prevalence, early diagnosis and awareness, global initiatives in…
Macular Edema and Macular Degeneration Market to Reach $22.51 Billion by 2034
The global macular edema and macular degeneration market, valued at $10.33 billion in 2023, is on track to grow at a remarkable compound annual growth rate (CAGR) of 7.34%, reaching $22.51 billion by 2034. This substantial market expansion is being fueled by rising treatment innovations, an increasing global prevalence of related diseases, and a surge in technological advancements in diagnostics and therapies.
Download White Paper: https://www.towardshealthcare.com/download-statistics/5375
Market Overview and Key Drivers
The macular…
Macular Edema and Macular Degeneration Market Size, Trends, Growth, Outlook 2024 …
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Macular Edema and Macular Degeneration Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $12.84…
Macular Edema and Macular Degeneration Market: Key Trends, Competitor Analysis, …
"Exploring the Global Macular Edema and Macular Degeneration Market: A Comprehensive Overview
Insights into Macular Edema and Macular Degeneration Market: Global Trends and Analysis
Macular Edema and Macular Degeneration Industry - Key Market Dynamics and Trends
The macular edema and macular degeneration market size has grown strongly in recent years. It will grow from $8.84 billion in 2023 to $9.65 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The…
